TABLE 2.
Specimen | Specimen type | Hepatitis C clinical status | Histopathology |
---|---|---|---|
A-1 | Posttransplant biopsy (3 mo) | Nondiseased | NSPAa |
A-2 | Posttransplant biopsy (24 mo) | Nondiseased | NSPA |
B-1 | Posttransplant biopsy (5 wk) | Nondiseased | NSPA |
B-2 | Posttransplant biopsy (24 wk) | Mild acute hepatitis | Inflammation, necrosis |
C | Nontransplant biopsy | Chronic hepatitis | Inflammation, necrosis, mild fibrosis |
D | Liver explant | End-stage liver disease | Cirrhosis |
E | Liver explant | End-stage liver disease | Cirrhosis |
NSPA, no specific pathological abnormality.